These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2730815)
1. Plasma retention and metabolic fate of hemoglobin modified with an interdimeric covalent cross link. Keipert PE; Verosky M; Triner L ASAIO Trans; 1989; 35(2):153-9. PubMed ID: 2730815 [TBL] [Abstract][Full Text] [Related]
2. The role of the kidneys in the excretion of chemically modified hemoglobins. Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Winslow RM Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):737-45. PubMed ID: 1391505 [TBL] [Abstract][Full Text] [Related]
3. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate. Bleeker WK; van der Plas J; Feitsma RI; Agterberg J; Rigter G; de Vries-van Rossen A; Pauwels EK; Bakker JC J Lab Clin Med; 1989 Feb; 113(2):151-61. PubMed ID: 2915180 [TBL] [Abstract][Full Text] [Related]
4. Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate. Bleeker WK; van der Plas J; Agterberg J; Rigter G; Bakker JC J Lab Clin Med; 1986 Nov; 108(5):448-55. PubMed ID: 3772225 [TBL] [Abstract][Full Text] [Related]
5. Effect of coupling of 2-nor-2-formylpyridoxal 5'-phosphate to stroma-free hemoglobin on oxygen affinity and tissue oxygenation. Studies in the isolated perfused rat liver under conditions of normoxia and stagnant hypoxia. Van der Plas J; de Vries-van Rossen A; Bleeker WK; Bakker JC J Lab Clin Med; 1986 Sep; 108(3):253-60. PubMed ID: 3746098 [TBL] [Abstract][Full Text] [Related]
6. Purification and physical characteristics of a hemoglobin solution modified by coupling to 2-nor-2-formylpyridoxal 5'-phosphate (NFPLP). van der Plas J; de Vries-Van Rossen A; Koorevaar JJ; Buursma A; Zijlstra WG; Bakker JC Transfusion; 1988; 28(6):525-30. PubMed ID: 2461607 [TBL] [Abstract][Full Text] [Related]
7. Rat maze performance after infusion of cross-linked hemoglobin solution. Przybelski RJ; Kant GJ; Leu JR; Bounds MJ; Winslow RM Biomater Artif Cells Artif Organs; 1989; 17(5):583-96. PubMed ID: 2627577 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies in the rat on a o-raffinose polymerized human hemoglobin. Hsia JC; Song DL; Er SS; Wong LT; Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Hess JR; Winslow RM Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):587-95. PubMed ID: 1391482 [TBL] [Abstract][Full Text] [Related]
10. Functional properties of a new crosslinked hemoglobin designed for use as a red cell substitute. Keipert PE; Adeniran AJ; Kwong S; Benesch RE Transfusion; 1989; 29(9):768-73. PubMed ID: 2588315 [TBL] [Abstract][Full Text] [Related]
11. Enhanced oxygen unloading by an interdimerically crosslinked hemoglobin in an isolated perfused rabbit heart. Benesch R; Triner L; Benesch RE; Kwong S; Verosky M Proc Natl Acad Sci U S A; 1984 May; 81(9):2941-3. PubMed ID: 6585838 [TBL] [Abstract][Full Text] [Related]
13. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models. Conover CD; Linberg R; Shum KL; Shorr RG Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932 [TBL] [Abstract][Full Text] [Related]
14. Allosteric kinetics and equilibria of triligated, cross-linked hemoglobin. Zhao M; Jiang J; Greene M; Andracki ME; Fowler SA; Walder JA; Ferrone FA Biophys J; 1993 May; 64(5):1520-32. PubMed ID: 8324188 [TBL] [Abstract][Full Text] [Related]
15. The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. Yoshida M; Roth RI; Levin J J Lab Clin Med; 1995 Aug; 126(2):151-60. PubMed ID: 7636388 [TBL] [Abstract][Full Text] [Related]
17. HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Snyder SR; Welty EV; Walder RY; Williams LA; Walder JA Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7280-4. PubMed ID: 3478694 [TBL] [Abstract][Full Text] [Related]
18. The effects of alpha-alpha cross-linked hemoglobin on the feeding and locomotor activity of rats. Bauman RA; Przybelski RJ; Bounds MJ Physiol Behav; 1991 Jul; 50(1):205-11. PubMed ID: 1946718 [TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of pyridoxalated-polymerized hemoglobin solution. Friedman HI; De Venuto F; Schwartz BD; Nemeth TJ Surg Gynecol Obstet; 1984 Nov; 159(5):429-35. PubMed ID: 6495140 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier. Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]